Description
General description
Copper(II) acetylacetonate (Cu(acac)2) is an organometallic compound recognized for its low decomposition temperature of 286 °C, making it an ideal precursor for the synthesis of copper and copper oxide nanoparticles. It can be used in electronics, ceramics, and catalysis.
Application
Dextromethorphan as a moderator of reward deficiency: Research explored Dextromethorphan′s role in moderating reward deficiency associated with serotonin transporter availability in MDMA-treated animals, indicating its potential application in neuropsychopharmacology and addiction studies (Chiu et al., 2024).
Pharmacotherapies targeting GABA-Glutamate neurotransmission: A review discussed the use of Dextromethorphan among pharmacotherapies targeting GABA-glutamate neurotransmission for treatment-resistant depression, highlighting its role as an NMDA receptor antagonist and sigma-1 receptor agonist (Vecera et al., 2023).
Experience-dependent psychological effects: A double-blind study compared the psychological effects of Dextromethorphan and Psilocybin in healthy volunteers, examining their experience-dependent and enduring impacts, relevant in clinical psychology and psychedelic research (Mathai et al., 2023).
Copper(II) acetylacetonate can be used as: a precursor to synthesize copper based chalcogenides Cu2NiSnS4 CNTS nanocrystals, which are then combined with gold nanoparticles (Au NPs) to form the core-shell structure. Resulting Au/CNTS nanocrystals serve as photoactive materials in hybrid photodetectors, demonstrating superior optoelectronic performance, such as high responsivity and specific detectivity in the visible light spectrum.
a precursor in the synthesis of Cu-Ga-Zn-S nanorods through a high-temperature injection method, for efficient photocatalytic water splitting.
a copper precursor in the one-pot synthesis of the core/shell PtCu nanoparticles. These bimetallic PtCu nanoparticles exhibit higher activity in catalyzing the oxygen reduction reaction.